Skip to main content

Advertisement

Log in

A new cardiotonic agent, OPC-8212, elevates the myocardial oxygen consumption versus pressure-volume area (PVA) relation in a similar manner to catecholamines and calcium in canine hearts

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

We studied the effect of a new positive inotropic agent, OPC-8212 (3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-l-piperazinyl]-2(1H)-quinolinone), on the relation between left ventricular oxygen consumption (VO2) and pressure-volume area (PVA) in excised cross-circulated dog hearts. PVA represents the total mechanical energy generated by ventricular contraction. OPC-8212 increased the contractility index, Emax, by 59%±36% from 7.6±4.3 to 11.1±4.6 mmHg/(ml/100 g LV [leftventricle]). OPC-8212 elevated the VO2-PVA relation without a significant change in its slope. Namely, OPC-8212 did not affect the mechanical efficiency of the contractile machinery from the PVA-dependent fraction of VO2 to PVA, but increased the PVA-independent fraction of VO2 which is related with non-mechanical processes of contraction. This effect suggested an increased energy expenditure for excitation-contraction coupling. These results associated with the enhanced contractile state by OPC-8212 were both qualitatively and quantitatively similar to those obtained with catecholamines and calcium in our previous study. This suggests that OPC-8212, catecholamines, and calcium have similar effects on intracellular Ca2+ concentration and enhanced ventricular contractility.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Katz AM (1984) Excitation-contraction coupling and Ca2+. In: Abe H (ed) Regulation of cardiac function. Japan Scientific Societies Press, Tokyo, pp 3–9

    Google Scholar 

  2. Gibbs CL (1978) Cardiac energetics. Physiol Rev 58: 174–254

    PubMed  Google Scholar 

  3. Tominaga M, Yo E, Ogawa H, Yamashita S, Yabuuchi Y, Nakagawa K (1984) Studies on positive inotropic agent. I. Synthesis of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone and related compounds. Chem Pharm Bull 32:2100–2110

    PubMed  Google Scholar 

  4. Taira N, Endoh M, Iijima T, Satoh K, Yanagisawa T, Yamashita S, Maruyama M, Kawada M, Morita T, Wada Y (1984) Mode and mechanism of action of 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), a novel positive inotropic drug, on the dog heart. Arzneimittelforsch / Drug Res 34: 347–355

    Google Scholar 

  5. Endo M (1984) The effect of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]2-(1H)-quinolinone (OPC-8212) on thin bundles of skinned fibers from cardiac muscle. Arzneimittelforsch / Drug Res 34: 380–383

    Google Scholar 

  6. Endoh M, Yanagisawa T, Taira N, Blinks JR (1986) Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Circulation 73 (Suppl III): III-117–III-133

    Google Scholar 

  7. Miyazaki S, Sasayama S, Nakamura Y, Kihara Y, Susawa T, Kawai C (1986) Acute hemodynamic effects of a new positive inotropic agent, 3,4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in conscious and anesthetized dogs. J Cardiovasc Pharmacol 8: 14–20

    PubMed  Google Scholar 

  8. Grupp G, Grupp IL, Kojima M, Sperelakis N, Tsuchiya Y, Hosokawa T, Schwartz A (1986) Hemodynamic and electrophysiological effects of a novel positive inotropic drug, OPC-8212, in normal and “failing” guinea pig heart preparation. J Cardiovasc Pharmacol 8: 428–440

    PubMed  Google Scholar 

  9. Sasayama S, Inoue M, Asanoi H, Kodama K, Hori M, Sakurai T, Kawai C (1986) Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failure. Heart Vessels 2: 23–28

    PubMed  Google Scholar 

  10. Maruyama Y, Nishioka O, Watanabe J, Keitoku M, Satoh S, Isoyama S, Ashikawa K, Ino-Oka E, Takishima T (1986) Effect of OPC-8212, a new positive inotropic agent, and dobutamine on left ventricular global and ischemic regional functions and coronary hemodynamics under coronary artery stenosis. J Cardiovasc Pharmacol 8: 161–169

    PubMed  Google Scholar 

  11. Suga H (1979) Total mechanical energy of a ventricle model and cardiac oxygen consumption. Am J Physiol 236: H498-H505

    PubMed  Google Scholar 

  12. Suga H, Hisano R, Goto Y, Yamada O, Igarashi Y (1983) Effect of positive inotropic agents on relation between oxygen consumption and systolic pressure-volume area in canine left ventricle. Circ Res 53: 306–318

    PubMed  Google Scholar 

  13. Nazawa T, Yasumura Y, Futaki S, Tanaka N, Igarashi Y, Goto Y, Suga H (1987) Relation between oxygen consumption and pressure-volume area of in situ dog heart. Am J Physiol 253: H31-H40

    PubMed  Google Scholar 

  14. Suga H, Hayashi T, Shirahata M (1981) Ventricular systolic pressure-volume area as predictor of cardiac oxygen consumption. Am J Physiol 240: H39-H44

    PubMed  Google Scholar 

  15. Suga H, Hayashi T, Shirahata M, Suehiro S, Hisano R (1981) Regression of cardiac oxygen consumption on ventricular pressure-volume area in dog. Am J Physiol 240: H320-H325

    PubMed  Google Scholar 

  16. Shepherd AP, Burgar CG (1977) A solid-state arteriovenous oxygen difference analyzer for flowing blood. Am J Physiol 232: H437-H440

    PubMed  Google Scholar 

  17. Suga H, Sagawa K, Shoukas AA (1973) Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effect of epinephrine and heart rate on the ratio. Circ Res 32: 314–322

    PubMed  Google Scholar 

  18. Suga H, Sagawa K (1974) Instantaneous pressure-volume relationship and their ratio in the excised, supported canine left ventricle. Circ Res 35: 117–126

    PubMed  Google Scholar 

  19. Suga H, Hisano R, Ninomiya I (1982) Digital on-line computation of a predictor of cardiac oxygen consumption. Left ventricular pressure-volume area. Jpn Heart J 23: 749–758

    PubMed  Google Scholar 

  20. Suga H, Goto Y, Yasumura Y, Nozawa T, Futaki S, Tanaka N, Uenishi M (1988) O2 consumption of dog heart under decreased coronary perfusion and propranolol. Am J Physiol 254: H292-H303

    PubMed  Google Scholar 

  21. Snedecor GN, Cochran WG (1980) Statistical Method (7th ed.) Iowa State University Press, Ames, Iowa, pp 365–388

    Google Scholar 

  22. Klocke FJ, Kaiser GA, Ross J, Braunwald E (1965) Mechanism of increase of myocardial oxygen uptake produced by catecholamines. Am J Physiol 209: 913–918

    PubMed  Google Scholar 

  23. Klocke FJ, Braunwald E, Ross J (1966) Oxygen cost of electrical activation of the heart. Circ Res 18: 357–365

    PubMed  Google Scholar 

  24. Suga H, Igarashi Y, Yamada O, Goto Y (1985) Mechanical efficiency of the left ventricle as a function of preload, afterload, and contractility. Heart Vessels 1: 3–8

    PubMed  Google Scholar 

  25. Burkhoff D, Yue DT, Oikawa RY, Franz MR, Schaefer J, Sagawa K (1987) Influence of ventricular contractility on non-work-related myocardial oxygen consumption. Heart Vessels 3: 66–72

    PubMed  Google Scholar 

  26. Tada M, Yamamoto T, Tonomura Y (1978) Molecular mechanisms of active calcium transport by sarcoplasmic reticulum. Physiol Rev 58: 1–79

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Partly supported by a Grant-in-Aid (61480102) for Scientific Research from the Ministry of Education, Science, and Culture, and a Research Grant (60C-3) for Cardiovascular Diseases from the Ministry of Health and Welfare of Japan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Futaki, S., Nozawa, T., Yasumura, Y. et al. A new cardiotonic agent, OPC-8212, elevates the myocardial oxygen consumption versus pressure-volume area (PVA) relation in a similar manner to catecholamines and calcium in canine hearts. Heart Vessels 4, 153–161 (1988). https://doi.org/10.1007/BF02058428

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02058428

Key words

Navigation